Dyne Therapeutics Inc.-4.33% $1.44B ...

Roche Holding AG Akt-0.90% CHF214.52B ...

Rein Therapeutics (RNTX), formerly known as Aileron Therapeutics (ALRN), has changed its name to Rein Therapeutics. The new name, logo, website, and branding elements reflect the Company’s ...

Changes to the Phase 2 study endpoints after Neumora acquired the rights to navacaprant from Blackthorn Therapeutics as part of a merger completed in 2020 may have undermined the integrity of the ...

Fraser Murray, PhD, CEO, Pheno Therapeutics. Image Credit: Pheno Therapeutics A selective GPR17 (G protein-coupled receptor 17) antagonist, PTD802 is a novel small molecule therapeutic designed to ...

Please use one of the following formats to cite this article in your essay, paper or report: APA Pheno Therapeutics. (2025, January 15). Pheno Therapeutics granted clinical trial authorization for ...

Cartesian Therapeutics (RNAC) highlighted its recent progress and outlined its 2025 strategic priorities across its pipeline of mRNA cell therapy product candidates. Phase 3 AURORA trial of ...

A little backstory is that Neumora Therapeutics acquired Blackthorn Therapeutics, which was running a phase 2 study beforehand. However, it was only recruiting patients with mild-to-moderate MDD.

After hours: January 17 at 7:47:19 PM EST Loading Chart for NKTR ...

After hours: January 17 at 4:33:16 PM EST Loading Chart for ALDX ...

Here are some before and after pictures of the company's wordmark and logo. Here's a look at how the new wordmark and logo will appear on storefronts. Social media users react to Walmart's logo ...